Aphios Home Page
Company
Infectious Diseases
Oncology and CNS Disorders
Nutraceuticals
Product Pipeline
Purchase Products
Technology Platforms
Technology Platforms
Patents

Press Releases

Contact Aphios

 

 

Abbott Laboratories, Inc., Abbott Park, Illinois

Aphios Corporation has isolated and purified pilot quantities of a taxols intermediate, 9-dihydro-13-acetylbaccatin III (9-DHAB), for Abbott Laboratories, Inc., Abbott Park, Illinois.

Abbott Laboratories is a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products.  The company employs 56,000 people and markets its products in more than 130 countries. In 1998, the company’s sales and net earnings were $12.5 billion and $2.3 billion, respectively, with diluted earnings per share of $1.51.  Abbott Laboratories has been in the business of improving lives for more than a century and is dedicated to discovering, developing and marketing innovative health care solutions across the spectrum of health care. (www.abbott.com).

 

Home l Company | Infectious Diseases | Oncology | Nutraceuticals | Product Pipeline | Purchase Products | Technology Platforms | Equipment |Patents | Press Releases | Contact Aphios

©1999- 2007 Aphios® Corporation
All rights reserved